Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Saba Capital Management, L.P.10% Owner | Open-market purchase | BUY | $26K 2,504 sh |
| Oct 29, 2026 traded Oct 28, 2026 |
| 22 | Leslie Ericka TChief Administrative Officer | Open-market sale | SELL | $93K 100 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 22 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | Open-market sale · 10b5-1 plan | SELL | $1.46M 3,430 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 22 | Melin AlfEVP & Chief Financial Officer | Tax withholding | F | $4.66M 65.3K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 22 | Leslie Ericka TChief Administrative Officer | Open-market sale | SELL | $36K 40 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 22 | Saba Capital Management, L.P.10% Owner | Open-market purchase | BUY | $12K 1,050 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 22 | Rounce JustinEVP & Chief Technology Officer | Tax withholding | F | $4.66M 65.3K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 21 | Zlotnicka Eva T.Director | Grant or award | A | — 9,840 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 21 | Hopmayer Jeffrey ScottDirector | Grant or award | A | $31K 455.2K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | Oct 29, 2026 traded Oct 15, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | Oct 29, 2026 traded Oct 15, 2026 |
| 20 | Norsa MicheleDirector | Open-market sale | SELL | $106K 8,000 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 20 | Yetter Richard ChristopherDirector | Grant or award | A | $125K 138.1K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 19 | Chapman Steven LeonardDirector, CEO AND PRESIDENT | Open-market sale · 10b5-1 plan | SELL | $919K 2,264 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 19 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $359K 884 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 19 | Biswas SanjitDirector, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $983K 23.7K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 19 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $410K 1,010 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 19 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $413K 968 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 19 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $383K 898 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 19 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $317K 781 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 19 | Biswas SanjitDirector, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $717K 17.1K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 19 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $350K 8,013 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 19 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $550K 13.1K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 19 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $511K 1,198 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 19 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $317K 781 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 19 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $495K 1,162 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 19 | Rabinowitz MatthewDirector, EXECUTIVE CHAIRMAN | Open-market sale · 10b5-1 plan | SELL | $698K 1,718 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 19 | Biswas SanjitDirector, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $363K 8,304 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 18 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $603K 1,681 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 18 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $845K 2,331 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 17 | Bokan Michael WDirector | Grant or award | A | — 7,415 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 17 | Lucky Mark BurdonDirector, CFO and Interim Principal, 10% Owner | Grant or award | A | — 4,200 sh | Oct 29, 2026 traded Apr 16, 2026 |
| 17 | DeBiasio Alice MariePresident, FCD | Option exercise | M | — 4,505 sh | Oct 29, 2026 traded Oct 29, 2026 |
| 17 | Abernethy James SDirector | Open-market sale | SELL | $44K 1,000 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 17 | Jensen Mark EdwinDirector | Grant or award | A | — 7,415 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 17 | Walsh Paul V JrDirector | Grant or award | A | — 7,415 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 17 | Abernethy James SDirector | Open-market sale | SELL | $26K 600 sh | Oct 29, 2026 traded Oct 29, 2026 |
| 17 | Toler William DouglasDirector, Chief Executive Officer, Executive Chairman of Board | Grant or award | A | $50K 55.2K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 17 | Starke JeffEVP, CHIEF INFORMATION OFFICER | Open-market sale | SELL | $279 3 sh | Oct 29, 2026 traded Oct 29, 2026 |
| 17 | Mattes Andreas WDirector | Grant or award | A | — 7,415 sh | Oct 29, 2026 traded Oct 27, 2026 |